Clinical trial
Can Stellar Ganglion Blockage be an Alternative Treatment for Refractory Ventricular Arrhythmias?
NCT05712122 is registered in ClinicalTrials.gov with Adana City Training and Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Can Stellar Ganglion Blockage be an Alternative Treatment for Refractory Ventricular Arrhythmias?
- Lead sponsor
- Adana City Training and Research Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 1, 2021
- Completion date
- March 24, 2022
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac arrhythmia